Concepedia

Laura Giannetta

LG

12

Publications

1.6K

Citations

10

H-Index

2002

Active since

Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(Current)

University of Milan

Ospedale Maggiore

Azienda Ospedaliera di Perugia

Humanitas University

Laura Giannetta is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2002–2021

12

Publications

12

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

Alexander Drilon, Salvatore Siena, Sai‐Hong Ignatius Ou et al. · Cancer Discovery · 2017 · 795 citations · Full text

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Carmine Pinto, Francesca Di Fabio, Salvatore Siena et al. · Annals of Oncology · 2006 · 285 citations · Full text

, , +9

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

Carmine Pinto, Francesca Di Fabio, Carlo Barone et al. · British Journal of Cancer · 2009 · 142 citations · Full text

Malignant peritoneal mesothelioma: a multicenter study on 81 cases

Vincenzo de Pangher Manzini, Leonardo Recchia, Mara A. Cafferata et al. · Annals of Oncology · 2009 · 124 citations

, , +3

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

Alessio Amatu, Alessio Somaschini, Giulio Cerea et al. · British Journal of Cancer · 2015 · 84 citations · Full text

Rows per page

1–5 of 12